Correlation Between Cyclacel Pharmaceuti and Blackrock 6040

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cyclacel Pharmaceuti and Blackrock 6040 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyclacel Pharmaceuti and Blackrock 6040 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyclacel Pharmaceuti and Blackrock 6040 Target, you can compare the effects of market volatilities on Cyclacel Pharmaceuti and Blackrock 6040 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyclacel Pharmaceuti with a short position of Blackrock 6040. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyclacel Pharmaceuti and Blackrock 6040.

Diversification Opportunities for Cyclacel Pharmaceuti and Blackrock 6040

0.1
  Correlation Coefficient

Average diversification

The 3 months correlation between Cyclacel and Blackrock is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Cyclacel Pharmaceuti and Blackrock 6040 Target in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blackrock 6040 Target and Cyclacel Pharmaceuti is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyclacel Pharmaceuti are associated (or correlated) with Blackrock 6040. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blackrock 6040 Target has no effect on the direction of Cyclacel Pharmaceuti i.e., Cyclacel Pharmaceuti and Blackrock 6040 go up and down completely randomly.

Pair Corralation between Cyclacel Pharmaceuti and Blackrock 6040

Given the investment horizon of 90 days Cyclacel Pharmaceuti is expected to under-perform the Blackrock 6040. In addition to that, Cyclacel Pharmaceuti is 5.4 times more volatile than Blackrock 6040 Target. It trades about -0.11 of its total potential returns per unit of risk. Blackrock 6040 Target is currently generating about -0.06 per unit of volatility. If you would invest  1,465  in Blackrock 6040 Target on May 12, 2022 and sell it today you would lose (126.00)  from holding Blackrock 6040 Target or give up 8.6% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cyclacel Pharmaceuti  vs.  Blackrock 6040 Target

 Performance (%) 
       Timeline  
Cyclacel Pharmaceuti 
Cyclacel Performance
1 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Cyclacel Pharmaceuti are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak fundamental indicators, Cyclacel Pharmaceuti may actually be approaching a critical reversion point that can send shares even higher in September 2022.

Cyclacel Price Channel

Blackrock 6040 Target 
Blackrock Performance
3 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Blackrock 6040 Target are ranked lower than 3 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Blackrock 6040 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Blackrock Price Channel

Cyclacel Pharmaceuti and Blackrock 6040 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cyclacel Pharmaceuti and Blackrock 6040

The main advantage of trading using opposite Cyclacel Pharmaceuti and Blackrock 6040 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyclacel Pharmaceuti position performs unexpectedly, Blackrock 6040 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blackrock 6040 will offset losses from the drop in Blackrock 6040's long position.

Cyclacel Pharmaceuti

Pair trading matchups for Cyclacel Pharmaceuti

The idea behind Cyclacel Pharmaceuti and Blackrock 6040 Target pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Blackrock 6040 Target

Pair trading matchups for Blackrock 6040

GM vs. Blackrock 6040
B of A vs. Blackrock 6040
Twitter vs. Blackrock 6040
Walker Dunlop vs. Blackrock 6040
Salesforce vs. Blackrock 6040
Vmware vs. Blackrock 6040
Dupont Denemours vs. Blackrock 6040
Alphabet vs. Blackrock 6040
SP 500 vs. Blackrock 6040
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Blackrock 6040 as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Blackrock 6040's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Blackrock 6040's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Blackrock 6040 Target.
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
CEO Directory
Screen CEOs from public companies around the world
Go